NCT02711956 - A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG

ZEN003694

DRUG

Enzalutamide

Trial Locations (8)

University of California Los Angeles Medical Center, Los Angeles

University of California San Francisco Medical Center, San Francisco

Karmanos Cancer Institute, Detroit

Karmanos Cancer Institute, Farmington Hills

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medicine - New York Presbyterian, New York

Oregon Health & Science University, Portland

Seattle Cancer Care Alliance, Seattle